Literature DB >> 25755569

Terbinafine induced liver injury: a case report.

Narendra S Choudhary1, Hardik Kotecha2, Neeraj Saraf1, Dheeraj Gautam3, Sanjiv Saigal1.   

Abstract

Drug induced liver injury (DILI) is a cause of significant morbidity; timely diagnosis is important and requires a high index of suspicion. Terbinafine induced liver injury is rare. We report a case of Terbinafine induced hepatitis-cholestatic injury. The patient had a prolonged recovery phase lasting 3 months after discontinuation of drug.

Entities:  

Keywords:  DILI, drug induced liver injury; Terbinafine; ULN, upper limit of normal; drug induced liver injury; liver

Year:  2014        PMID： 25755569      PMCID： PMC4284205          DOI： 10.1016/j.jceh.2014.03.040

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN： 0973-6883


  9 in total

1.  Terbinafine hepatotoxicity resulting in chronic biliary ductopenia and portal fibrosis.

Authors:  Frank A Anania; Lionel Rabin
Journal:  Am J Med       Date:  2002-06-15       Impact factor: 4.965

2.  Ursodeoxycholic acid for terbinafine-induced toxic hepatitis.

Authors:  Erhan Agca; Ali Akcay; Halis Simsek
Journal:  Ann Pharmacother       Date:  2004-04-30       Impact factor: 3.154

3.  Terbinafine induced prolonged cholestasis: case report and review of the literature.

Authors:  Omer Topalak; Feyzullah Uçmak; Ozgül Sağol; Hale Akpinar; Omür Gönen
Journal:  Turk J Gastroenterol       Date:  2002-09       Impact factor: 1.852

4.  Terbinafine-induced hepatic failure requiring liver transplantation.

Authors:  Zeeshan Perveze; Mark W Johnson; Raymond A Rubin; Marty Sellers; Carlos Zayas; Jody L Jones; Rosemary Cross; Kimberly Thomas; Bradley Butler; Roshan Shrestha
Journal:  Liver Transpl       Date:  2007-01       Impact factor: 5.799

5.  Identification of a reactive metabolite of terbinafine: insights into terbinafine-induced hepatotoxicity.

Authors:  S L Iverson; J P Uetrecht
Journal:  Chem Res Toxicol       Date:  2001-02       Impact factor: 3.739

Review 6.  Case definition and phenotype standardization in drug-induced liver injury.

Authors:  G P Aithal; P B Watkins; R J Andrade; D Larrey; M Molokhia; H Takikawa; C M Hunt; R A Wilke; M Avigan; N Kaplowitz; E Bjornsson; A K Daly
Journal:  Clin Pharmacol Ther       Date:  2011-05-04       Impact factor: 6.875

Review 7.  Practical guidelines for diagnosis and early management of drug-induced liver injury.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

Review 8.  Hepatitis associated with terbinafine therapy: three case reports and a review of the literature.

Authors:  A K Gupta; J Q del Rosso; C W Lynde; G H Brown; N H Shear
Journal:  Clin Exp Dermatol       Date:  1998-03       Impact factor: 3.470

Review 9.  Causality assessment of drug-induced hepatotoxicity: promises and pitfalls.

Authors:  Max A Shapiro; James H Lewis
Journal:  Clin Liver Dis       Date:  2007-08       Impact factor: 6.126
  9 in total
  5 in total

1.  Suspected adverse reactions associated with herbal products used for weight loss: spontaneous reports from the Italian Phytovigilance System.

Authors:  Gabriela Mazzanti; Annabella Vitalone; Roberto Da Cas; Francesca Menniti-Ippolito
Journal:  Eur J Clin Pharmacol       Date:  2019-08-19       Impact factor: 2.953

2.  Comprehensive kinetic and modeling analyses revealed CYP2C9 and 3A4 determine terbinafine metabolic clearance and bioactivation.

Authors:  Dustyn A Barnette; Mary A Davis; Noah Flynn; Anirudh S Pidugu; S Joshua Swamidass; Grover P Miller
Journal:  Biochem Pharmacol       Date:  2019-10-09       Impact factor: 5.858

3.  In Vitro Triple Combination of Antifungal Drugs against Clinical Scopulariopsis and Microascus Species.

Authors:  Limin Yao; Zhe Wan; Ruoyu Li; Jin Yu
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

4.  Quinolines derivatives as promising new antifungal candidates for the treatment of candidiasis and dermatophytosis.

Authors:  Gabriella da Rosa Monte Machado; Denise Diedrich; Thaís Carine Ruaro; Aline Rigon Zimmer; Mário Lettieri Teixeira; Luís Flávio de Oliveira; Mickael Jean; Pierre Van de Weghe; Saulo Fernandes de Andrade; Simone Cristina Baggio Gnoatto; Alexandre Meneghello Fuentefria
Journal:  Braz J Microbiol       Date:  2020-07-31       Impact factor: 2.476

5.  Analysis of Time-Series Gene Expression Data to Explore Mechanisms of Chemical-Induced Hepatic Steatosis Toxicity.

Authors:  Alejandro Aguayo-Orozco; Frederic Yves Bois; Søren Brunak; Olivier Taboureau
Journal:  Front Genet       Date:  2018-09-18       Impact factor: 4.599
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.